Xenetic Biosciences (XBIO) Stock Highlights

4.29 | +0.23%

2024-12-21 07:44:29

Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patients malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer.

Statistics

Range Today

4.16 4.31

Volume Today 3.6K

Range 1 Year

2.78 5.2

Volume 1 Year 3.07M

Range 3 Year

2.4 14.8

Volume 3 Year 9.09M

Range 10 Year

2.4 1074

Volume 10 Year 119.18M

Highlights

Market Capitalization 5.8M (micro)

Floating Shares 1.18M

Current Price 4.29

Price To Earnings -1.24

Price To Revenue -0.59

Price To Book 0.78

Earnings Per Share -3.06

Payout Ratio 0%

Performance

Latest +0.23%

1 Month +12.6%

3 Months +14.1%

6 Months +7.25%

1 Year +28.06%

3 Years -67%

5 Years -70.41%

10 Years -99.3%

Benchmarks

Market Capitalization

358 / 368

Gross Profits

0 / 278

Total Revenue

220 / 300

Total Rank

368 / 368

Free Cashflow

63 / 352

Performance 5 years

201 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.